Greifswald, Germany

Ulrike Lindequist

USPTO Granted Patents = 3 


 

Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Ulrike Lindequist: Innovator in Medical Adhesives

Introduction

Ulrike Lindequist is a prominent inventor based in Greifswald, Germany. She has made significant contributions to the field of medical adhesives, holding three patents that showcase her innovative spirit and dedication to improving medical applications.

Latest Patents

Her latest patents include an adhesive for medical applications and means for haemostasis. This invention relates to adhesives specifically designed for medical use, detailing methods of their preparation and application. Another notable patent involves a kit that comprises individual components such as polymers with free amino groups, bridge molecules from various aromatic compounds, and polyphenoloxidases, particularly lignolytic polyphenoloxidases. The unique aspect of this kit is that the bridge molecules and polyphenoloxidases are not in contact with each other.

Career Highlights

Throughout her career, Ulrike has worked with notable companies, including Stryker Trauma GmbH and Ganomycin. Her experience in these organizations has allowed her to develop and refine her innovative ideas in the medical field.

Collaborations

Ulrike has collaborated with esteemed colleagues such as Andreas Werner Speitling and Philip Procter. These partnerships have contributed to her success and the advancement of her inventions.

Conclusion

Ulrike Lindequist stands out as a leading inventor in the realm of medical adhesives, with her patents reflecting her commitment to innovation and healthcare improvement. Her work continues to influence the medical industry positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…